comparemela.com

Latest Breaking News On - Biotrack capital - Page 1 : comparemela.com

Deals in brief: Atome raises USD 31 million from parent firm, Asia Partners closes second fund, multiple China and India deals, and more

Bringing you the latest news briefs on fundraising activities in the Asia Pacific.

Germany
Indonesia
Gobi
Qinghai
China
India
Dancheng
Zhejiang
Shanghai
Bengaluru
Karnataka
Philippines

Deals in brief: Semaai, Komunal, and OnCusp secure funding, Etherscan acquires Solscan, multiple China and India deals, and more

Bringing you the latest news briefs on fundraising activities in the Asia Pacific.

Indonesia
Philippines
Central-java
Jawa-tengah
Chennai
Tamil-nadu
India
Singapore
China
Hong-kong
Shanghai
Japan

HongShan-backed OnCusp Therapeutics snags $100m Series A

OnCusp Therapeutics has raised $100 million in a Series A funding round co-led by Novo Holdings, OrbiMed, and F-Prime Capital.

Shanghai
China
Japan
Zhongshan
Jiangxi
New-york
United-states
Japanese
Chong-xu
Eric-slosberg
Daiichi-sankyo
Diyong-xu

OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients

OnCusp Therapeutics Raises Oversubscribed $100 Million Series A Financing to Advance Portfolio of Assets for Cancer Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Wuxi
Jiangsu
China
Diyong-xu
Karen-hong
Sandy-fu
Blackbird-bioventures
Eric-slosberg
Jiacong-guo
Chong-xu

Chinese advanced polymer materials maker TopOlefin snags $139m in Series B round

TopOlefin Technology has raked in 1 billion yuan ($138.9 million) in a Series B round led by local PE investment firms Kingray Capital and Raystone Capital. 

Shangrong
Hainan
China
Shanghai
Japan
Japanese
Chinese
Ofound-angel
Jiangsu-libert
Topolefin-technology
Quzhou-based-topolefin-technology
Kingray-capital

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.